Impact of caffeic acid on aluminium chloride-induced dementia in rats

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 12, 2013, Pages 1745-1752

  Khan, Kafeel A ^a   Kumar, Nitesh ^a   Nayak, Pawan G ^a   Nampoothiri, Madhavan ^a   Shenoy, Rekha R ^a   Krishnadas, Nandakumar ^a   Rao, C Mallikarjuna ^a   Mudgal, Jayesh ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

acetylcholinesterase; aluminium chloride; caffeic acid; Morris water maze; oxidative stress

Indexed keywords

ACETYLCHOLINESTERASE; ALUMINUM CHLORIDE; CAFFEIC ACID; CATALASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; NITRITE; RIVASTIGMINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEMENTIA ACTIVITY; ARTICLE; BRAIN HOMOGENATE; BRAIN LEVEL; CHOLINERGIC TRANSMISSION; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MAZE TEST; MORRIS WATER MAZE TEST; NONHUMAN; OXIDATIVE STRESS; RAT;

ACETYLCHOLINESTERASE; ALUMINIUM CHLORIDE; CAFFEIC ACID; MORRIS WATER MAZE; OXIDATIVE STRESS;

ALUMINUM COMPOUNDS; ANIMALS; CAFFEIC ACIDS; CHLORIDES; CHOLINESTERASE INHIBITORS; DEMENTIA; MALE; NITRITES; PHENYLCARBAMATES; RATS; RATS, WISTAR;

EID: 84887949371     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12126     Document Type: Article

References (43)

1. Kawahara M,. Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimers Dis 2005; 2: 171-182.
2. Zatta P, et al. The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull 2003; 1: 15-28.
3. Campbell A,. The potential role of aluminium in Alzheimer's disease. Nephrol Dial Transplant 2002; 17: 17-20.
4. Wills MR, Savory J,. Water content of aluminum, dialysis dementia, and osteomalacia. Environ Health Perspect 1985; 63: 141-147.
5. Rifat SL, et al. Effect of exposure of miners to aluminium powder. Lancet 1990; 8724: 1162-1165.
6. Hewitt CD, et al. Aspects of aluminum toxicity. Clin Lab Med 1990; 2: 403-422.
7. Pratico D,. Lipid peroxidation and the aging process. Sci Aging Knowledge Environ 2002; 50: re5.
8. Walton JR,. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. J Inorg Biochem 2007; 9: 1275-1284.
9. Platt B, et al. Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain Res Bull 2001; 2: 257-267.
10. Sethi P, et al. Aluminium-induced electrophysiological, biochemical and cognitive modifications in the hippocampus of aging rats. Neurotoxicology 2008; 6: 1069-1079.
11. Niu Q, et al. The relationship between Bcl-gene expression and learning and memory impairment in chronic aluminum-exposed rats. Neurotox Res 2007; 3: 163-169.
12. Julka D, et al. Distribution of aluminum in different brain regions and body organs of rat. Biol Trace Elem Res 1996; 2: 181-192.
13. Kaur A, Gill KD,. Possible peripheral markers for chronic aluminium toxicity in Wistar rats. Toxicol Ind Health 2006; 1: 39-46.
14. Lal B, et al. Aluminum ingestion alters behaviour and some neurochemicals in rats. Indian J Exp Biol 1993; 1: 30-35.
15. Friedrich H,. Phenylpropanoid constituents of essential oils. Lloydia 1976; 1: 1-7.
16. Piazzon A, et al. Antioxidant activity of phenolic acids and their metabolites: synthesis and antioxidant properties of the sulfate derivatives of ferulic and caffeic acids and of the acyl glucuronide of ferulic acid. J Agric Food Chem 2012; 60: 12312-12323.
17. Natarajan K, et al. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci U S A 1996; 17: 9090-9095.
18. Pascual C, et al. Scavenging action of propolis extract against oxygen radicals. J Ethnopharmacol 1994; 1-2: 9-13.
19. Mehrotra A, et al. Ameliorative effect of caffeic acid against inflammatory pain in rodents. Eur J Pharmacol 2011; 1-3: 80-86.
20. Eser O, et al. The neuroprotective effects of caffeic acid phenethyl ester (CAPE) in the hippocampal formation of cigarette smoke exposed rabbits. Pathology 2007; 4: 433-437.
21. Kerman M, et al. Neuroprotective effects of caffeic acid phenethyl ester on experimental traumatic brain injury in rats. J Mol Histol 2012; 1: 49-57.
22. Sul D, et al. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. Life Sci 2009; 9-10: 257-262.
23. Anwar J, et al. Effects of caffeic acid on behavioral parameters and on the activity of acetylcholinesterase in different tissues from adult rats. Pharmacol Biochem Behav 2012; 2: 386-394.
24. Jeong CH, et al. Neuroprotective and anti-oxidant effects of caffeic acid isolated from Erigeron annuus leaf. Chin Med 2011; 6: 25.
25. Edwards JA, Brimijoin S,. Divergent regulation of acetylcholinesterase and butyrylcholinesterase in tissues of the rat. J Neurochem 1982; 5: 1393-1403.
26. Ellman GL, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
27. Shuchang H, et al. Protective effects of gastrodia elata on aluminium-chloride-induced learning impairments and alterations of amino acid neurotransmitter release in adult rats. Restor Neurol Neurosci 2008; 6: 467-473.
28. Morris R,. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 1: 47-60.
29. Lowry OH, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 1: 265-275.
30. Aebi H,. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
31. Moron MS, et al. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979; 1: 67-78.
32. Habig WH, et al. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 22: 7130-7139.
33. Hauss-Wegrzyniak B, et al. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res 1998; 2: 294-303.
34. Retz W, et al. Free radicals in Alzheimer's disease. J Neural Transm Suppl 1998; 54: 221-236.
35. Dudal S, et al. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Neurobiol Aging 2004; 7: 861-871.
36. Rubio-Perez JM, Morillas-Ruiz JM,. A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal 2012; 2012: 756357.
37. Nunomura A, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001; 8: 759-767.
38. Kumar V, et al. Aluminium-induced oxidative DNA damage recognition and cell-cycle disruption in different regions of rat brain. Toxicology 2009; 3: 137-144.
39. Aly HF, et al. Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease. Acta Biochim Pol 2011; 4: 513-520.
40. Di J, et al. Study on the interaction of copper-zinc superoxide dismutase with aluminum ions by electrochemical and fluorescent method. Spectrochim Acta A Mol Biomol Spectrosc 2006; 3-4: 896-900.
41. Behl C, et al. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994; 6: 817-827.
42. Pike CJ, et al. Beta-amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants. J Neurochem 1997; 4: 1601-1611.
43. Yang JQ, et al. Protection of mouse brain from aluminum-induced damage by caffeic acid. CNS Neurosci Ther 2008; 1: 10-16.